Lu Tie

机构：Peking University, Peking University Third Hospital · ORCID：0000-0003-4755-2091

发表论文 85 篇 · 总被引 2694 次 · h-index 27

代表论文

• Current strategies and progress for targeting the “undruggable” transcription factors (2022 · Acta Pharmacologica Sinica · 被引 69)
• Emodin prevents renal ischemia-reperfusion injury via suppression of CAMKII/DRP1-mediated mitochondrial fission (2021 · European Journal of Pharmacology · 被引 55)
• Elucidating pathway-selective biased CCKBR agonism for Alzheimer’s disease treatment (2025 · Cell · 被引 42)
• Ligand recognition and G protein coupling of the human itch receptor MRGPRX1 (2023 · Nature Communications · 被引 24)
• Single hormone or synthetic agonist induces G s /G i coupling selectivity of EP receptors via distinct binding modes and propagating paths (2023 · Proceedings of the National Academy of Sciences · 被引 24)
• The novel small molecule BH3 mimetic nobiletin synergizes with vorinostat to induce apoptosis and autophagy in small cell lung cancer (2023 · Biochemical Pharmacology · 被引 14)